24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
64.06% |
|
IL 2 FORCE FIELD BENCHMARKING |
35.94% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
36.17% |
|
ANTIBODY DYNAMICS SIMULATION |
32.21% |
|
IL 2 FORCE FIELD BENCHMARKING |
13.83% |
|
MEMBRANE TRANSPORT |
9.29% |
|
IL 2 DYNAMICS SIMULATIONS |
8.5% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
27.98% |
|
ANTIBODY DYNAMICS SIMULATION |
22.39% |
|
ANTIBODY DYNAMICS |
13.25% |
|
IL 2 FORCE FIELD BENCHMARKING |
9.69% |
|
ANTIBODY AFFINITY MATURATION |
9.37% |
|
IL 2 DYNAMICS SIMULATIONS |
6.32% |
|
IL 2 RECEPTOR DYNAMICS |
4.02% |
|
ALZHEIMERS |
3.35% |
|
MEMBRANE TRANSPORT |
.83% |
|
PARKINSONS |
.81% |
|
PLANT SUCROSE TRANSPORT |
.67% |
|
ATSTP10 SUCROSE TRANSPORT |
.67% |
|
UNSPECIFIED |
.65% |